The application of recombinant human collagen in tissue engineering

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Collagen is a primary structural protein in vertebrates, crucial for cellular support and tissue integrity.
• Current tissue engineering relies on animal-derived collagen, posing risks of impurity, immunogenicity, and disease transmission.
• Existing collagen sources present challenges in quality control and predictable performance for medical applications.

Purpose of the Study:

• To introduce recombinant human collagen as a superior alternative for tissue engineering scaffolds.
• To highlight the benefits of chemically defined, animal-component-free collagen for medical applications.
• To demonstrate the potential of recombinant collagen in regenerating various human tissues.

Main Methods:

• Production of triple-helical collagens using recombinant technology with identical amino acid sequences to native human collagen.
• Coexpression of prolyl hydroxylase genes to achieve equivalent proline hydroxylation and stability.
• Assembly of single triple-helical molecules into complex three-dimensional structures for scaffolding.

Main Results:

• Recombinant human collagen provides a reliable, predictable, and chemically defined source, free from animal-derived risks.
• Recombinant collagens exhibit stability comparable to naturally occurring materials.
• Demonstrated efficacy as a scaffold for bone repair when combined with recombinant bone morphogenetic protein.

Conclusions:

• Recombinant human collagen production enables the engineering of human tissues using a human-derived matrix.
• These collagens serve as efficient scaffolds for skin, cartilage, periodontal ligament, and bone regeneration.
• Recombinant collagen represents a significant advancement in developing safer and more effective regenerative medicine strategies.